Summarized by Masters of Longevity from PR Newswire.
Announcement of a new CE-marked PCR newborn screening kit that screens newborns simultaneously for three severe genetic disorders to speed diagnosis and follow-up.
Key Takeaways
- This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) simultaneously.
- The test simultaneously screens for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD).
